Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $6.54 Million - $7.67 Million
259,100 Added 47.73%
801,900 $22.4 Million
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $1.95 Million - $2.24 Million
-75,500 Reduced 12.21%
542,800 $15.1 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $1.77 Million - $2.3 Million
67,800 Added 12.32%
618,300 $17.8 Million
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $5.08 Million - $5.93 Million
158,200 Added 40.33%
550,500 $18.3 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $10.5 Million - $12.2 Million
-291,000 Reduced 42.59%
392,300 $14.4 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $41.4 Million - $53.8 Million
-1,049,900 Reduced 60.58%
683,300 $27.9 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $43.5 Million - $56.8 Million
1,042,100 Added 150.79%
1,733,200 $88.8 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $3.57 Million - $4.35 Million
81,500 Added 13.37%
691,100 $30.2 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $23.9 Million - $28.4 Million
-514,400 Reduced 45.77%
609,600 $32 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $80 Million - $99.1 Million
-1,747,800 Reduced 60.86%
1,124,000 $58.2 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $36 Million - $53.4 Million
871,100 Added 43.54%
2,871,800 $170 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $78.5 Million - $101 Million
2,000,700 New
2,000,700 $86.1 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.